En 2016, l’organisme communautaire montréalais RÉZO a fêté ses 25 ans d’engagement pour la santé et le bien-être des gais. Trois choses à savoir sur cet organisme unique au Québec.
Good news? On this World AIDS Day, 2016, there is a lot to report. The science of treatment and prevention has much to inspire agencies delivering needed services to people living with, and at risk of, HIV. We know that there are significant health benefits for people with HIV to begin treatment as soon as possible after diagnosis. Early treatment with good adherence in order to maintain an undetectable viral load allows an HIV-positive person to live a long and healthy life. A ground-breaking study called START (Strategic Timing of Antiretroviral Treatment) found that immediate treatment upon an HIV diagnosis...
Many of you may have noticed the ebb and flow of the community-based HIV movement, influenced by medical and scientific breakthroughs, funder priorities, community activism and larger political, social and economic forces. Throughout my 20-plus years in HIV community-based work and volunteering, I have tried to ground myself in a few bedrocks as a way of anchoring my work. The essential connection between health and human rights. The need for policies, programs and services grounded in evidence and lived experience. Recognition of the central role played by the social determinants of health. And a commitment to social justice and taking...
From its beginning, CATIE has shared information with people living with HIV so that they can take better care of their health. In Fall 2015, we undertook a national online survey to better understand the information needs of people living with HIV today. The survey results may confirm what you already know about your clients’ information needs. Or perhaps they contain a surprise or two. Whatever the case, the results help guide all of us in how we can best serve our clients.
In an era where sometimes difficult, science-based decisions are routinely required of both positive and negative individuals− think when to start treatment, or the relative benefits of PrEP vs condoms− are we doing enough to steer people away from bad decisions?
Vancouver is in the limelight again. This year’s International AIDS Society (IAS) Conference may have marked a watershed moment in our HIV response, with some similarity to the 1996 Vancouver AIDS conference when highly active antiretroviral therapy (HAART) hit the world stage.
